Delivery Order SPE2DB24D6041-SPE2DB25FKCAQ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,487.31 on December 4, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,002.58 to supply 60 tablets of Eliquis 5 mg, with an ultimate completion date of December 30, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. This award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,311.84 by the Defense Logistics Agency (DLA) on April 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, which is not set-aside, utilizes firm fixed pricing and carries an ultimate completion date of May 1, 2025. Performance of this order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $2,635.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order (Contract 4570345421) by the Defense Logistics Agency (DLA) on December 22, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price contract carries a ceiling value of $4,146.14 with an ultimate completion date of December 23, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $33,351.31 for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 18, 2025. The award represents a continuation of AmerisourceBergen's substantial role in supporting federal pharmaceutical procurement,...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCAQDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on May 6, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $2.754K. This is a firm fixed price delivery order with an ultimate completion date of May 7, 2025, to be fulfilled at the vendor's corporate office location in Conshohocken, PA. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999B and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Defense Logistics Agency Medical Supply Chain relies on AmerisourceBergen as a critical prime vendor for pharmaceutical procurement supporting military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The underlying IDC represents a strategic federal procurement approach enabling flexible medical commodity deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This specific delivery order for the anticoagulant Eliquis reflects routine pharmaceutical replenishment needs within the broader military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/6/25 |